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Summary 
During intrathymic negative selection by clonal deletion, crosslinking of the T cell receptor (TCR) 
induces cell death by delivering an apoptotic signal(s) to the nucleus along a calcium-dependent 
pathway.  We investigated  the reactivity of early precursor-containing  thymocytes to  Ca  2+- 
induced signals, and discovered a breakpoint in their sensitivity to calcium-mediated cell death 
(CMCD). CD25 +  CD8-4-  TCK- (triple negative [TN]) thymocytes stimulated with a calcium 
ionophore maintain their viability and precursor activity. By contrast, their immediate progeny, 
CD25-CD81~176  1~ (triple low [TL]) cells react to calcium elevation by abrogation  of 
precursor activity and apoptotic cell death. This developmental difference is specific for CMCD, 
since both CD25 +TN and CD25-TL cells are susceptible to steroid-induced  apoptosis. The 
presence of bcl-2 mRNA correlates directly to the resistance to CMCD- CD25 +  TN cells express 
it and CD25-TL cells do not. These experiments show that thymocytes become sensitive to 
Ca  2+-induced apoptosis as soon as they begin to express molecules that mediate thymic sdection, 
and suggest  that a concomitant downregulation of bcl-2  may mediate this phenomenon. 
T 
CR-generated, calcium-mediated signals are instrumental 
in inducing antigen-dependent proliferation  of mature 
T cells (1) and in mediating intrathymic clonal deletion of 
immature, self-reactive thymocytes (2-4). This latter pheno- 
menon, here termed calcium-mediated cell death (CMCD) 1, 
is a mainstay of the deletional T cell tolerance to intrathymi- 
cally expressed self-antigens and is mediated by the induc- 
tion of apoptosis (2-4). Apoptotic death process is character- 
ized  by  membrane blebbing,  nuclear condensation,  and 
fragmentation of DNA into oligonucleosomal units [5], and 
is encountered in most tissues at some stage of their develop- 
ment (for a review see reference 6).  Apoptosis  can also be 
induced in thymocytes by a variety of physical and chemical 
stimuli (for a review see reference 7), the best studied of  which 
is the effect of corticosteroids (5-7). The apoptotic signaling 
process induced by steroids  is  mediated via their nuclear 
receptor (8), and is most likely distinct from CMCD. In both 
cases, the ultimate effector of apoptotic DNA fragmentation 
1  Abbreviations used in this paper: CI, conversion index;  CMCD, calcium- 
mediated cell death; CsA, Cyclosporin A; Dex, dexamethasone; DN, double 
negative; DE CD8"4 + double positive; FCM, flow cytometry; GARIG, 
goat anti-rat IgG; HSA, heat stable antigen; PI, propidium iodide; SA, 
streptavidin; TN, CD8-4-TCR- triple negative; TL, CDS]o41oTCRc~fl  lo 
triple low. 
is believed to be a Ca2+-dependent endogenous endonudease 
(5, 7). 
T cell precursors that lack CD8 and the TCR and express 
little CD4 develop in the thymus via an ordered sequence 
of phenotypic changes into mature, TCR  hi cells of CD8 +  4- 
or CD8-4 + phenotype (for a review see reference 9). Most 
thymocytes die at  the TCR  int/l~ CD8hi4  hi double-positive 
(DP)  stage, due to a lack of positive selection or negative 
selection by donal deletion.  Both processes are determined 
by the specificity of the TCR. Virtually nothing is known 
about the regulation of CMCD signaling during T cell de- 
velopment and its  relationship  to the onset  of TCR-ot/3 
receptor expression. Two main possibilities can be envisioned. 
First, the CMCD pathway may exist and be ready to react 
to Ca  2+ elevation irrespective of the developmental stage of 
thymocytes. A prediction of this hypothesis would be that 
all thymocytes should be sensitive to CMCD. Second, the 
pathway does not exist,  or cannot transform Ca  2+  signals 
into apoptotic death until the onset of TCK expression. The 
implication  of this  hypothesis  is  that  TCR-  and TCR + 
thymocyte subsets should  differ in susceptibility  to Ca  2§ 
induced apoptosis. Both types of subsets should, by contrast, 
be sensitive to apoptosis induced by TCR/Ca2+-independent 
signals. We present findings consistent with the second hy- 
pothesis, and show evidence  suggesting a role for bcl-2 in medi- 
ating resistance to CMCD. 
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Mice.  Female BALB/c, C57BL/6 (The Jackson Laboratory, Bar 
Harbor,  ME),  B6.PL-thy-1 a  Cy,  B6-Ly-5.2  (Memorial  Sloan- 
Kettering animal facility), and B6D2 F1 mice (National Cancer In- 
stitute animal facility, Frederick, MD) were used at 4-8 wk of age. 
Reagents.  The original source,  purification, and conjugation 
to fluorochromes of rat mAbs 3.168, cxCD8; 2B6, c~CD4; PC61, 
~CD25;  IM 7.1, c~CD44; Jlld.2 ~  heat stable antigen (cxHSA); 
and M1/69, olHSA, are referenced in (10-12). AUele-spedfic IgG2a 
antibodies against Ly-5.1 (104-2.1) and Ly-5.2 (A20-1.7)  (13), ob- 
tained from Drs. S. Kimura and U. Hammerling (Memorial Sloan- 
Kettering Cancer Center), were detected using goat anti-mouse 
IgG2a-FITC antibody (Fisher Scientific, Malvern, PA). Purified goat 
anti-rat  IgG (GARIG,  Sigma Chemical Co.,  St.  Louis,  MO), 
c~CD4-PE, and ~Thy-I.2-FITC (Becton Dickinson & Co., Moun- 
tain View, CA), c~CD8-B (Coulter Corp., Hialeah, FL) streptavidin- 
TriColor (SA-TC; Caltag Laboratories,  San Francisco, CA), PMA 
(Sigma Chemical Co.), ionomycin (Boehringer Mannheim Corp., 
Indianapolis,  IN) and a guinea pig serum, a source of complement 
(GIBCO BRL, Gaithersburg, MD),  were purchased from com- 
mercial sources.  Cyclosporin A (CsA)  and dexamethasone (Dex) 
were obtained from the pharmacy of the Memorial Sloan-Kettering 
Cancer Center. 
Isolation and Stimulation of Thyraocyte Subsets.  HSA + double 
negative (DN) thymocytes were purified from total thymocytes by 
a combination of mAb plus C' depletion and positive selection by 
panning, as described (10-12).  HSA+DN cells were then panned 
on GARIG-coated dishes. GARIG-adherent fraction contained the 
cells that survived mAb and complement treatment but were coated 
with the rat oeCD8 and c~CD4 antibodies, owing to low expres- 
sion  of CD4 and CD8.  These CD81~176  l~ (triple low [TL]) 
cells were used for further studies. GARIG-nonadherent cells were 
further positively sdected on PC61-coated plates.  Adherent cells 
were recovered and used as CD25 + CD8-4-TCR-  (triple nega- 
tive [TN]) cells in experiments. Cross-contamination among the 
two subsets was negligible (CD25 +TN cells were usually >95% 
CD25 hi, whereas CD25-TL cells contained 4-12% CD25 ~~ cells) 
as reported previously [11, 12]). Alternatively, Jlld-adherent cells 
were sorted on the basis of CD25 versus  CD44 expression into 
CD25+CD44 -  (TN) and CD25-CD44-  (TL) fractions (14, 15). 
To isolate mature thymocytes, cells were treated with two cycles 
of Jlld plus C'. These ceUs were routinely <1%  HSA +. 
In vitro culture of thymocyte subsets was described previously 
(10). Concentration of stimuli was: ionomycin, 400 ng/ml; PMA, 
10 ng/ml; CsA, 1/~g/ml; and dexamethasone,  10 .7 M. These con- 
centrations were determined not to be nonspecifically toxic to cells 
(data  not  shown).  To maximize the action of CsA,  cells were 
pretreated with CsA 1 h before addition of ionomycin. CsA was 
continuously present in culture. After the culture, cells were washed, 
counted, and used in the assays described below. 
In Vitro and ln Vivo Precursor  Assays.  These assays were described 
before (10-12).  For the in vitro assay, cell phenotypes were ana- 
lyzed by flow cytometry (FCM) at endpoint. Conversion index (CI) 
was determined by dividing the percentage of DP with the per- 
centage of DN cells. This was empirically found to be the most 
accurate measure of conversion that can easily be used to compare 
different experiments. For the in vivo assay, thymocytes of host 
mice (congenic at Thy-1 or Ly-5 loci) were analyzed at indicated 
times after intrathymic injection of donor-type thymocyte subsets 
for the presence of donor-derived cells using Thy-1 or Ly-5 allele- 
specific mAbs. 
DNA Fragmentation Assay.  A quantitative assay of the DNA 
content in stimulated thymocyte subsets  (16) and the isolation of 
nuclei (17) were described before. Nuclei equivalent to 1.5  x  106 
cells were incubated with or without 10 mM MgC12 and 5 mM 
CaC12. After the incubation, propidium iodide (PI) was added at 
20/~g/ml.  P1 fluorescence was measured using a FACScan  |  flow 
cytometer (Becton Dickinson & Co.). The percentage of cells un- 
dergoing DNA fragmentation was determined as the number of 
cells with DNA content in the subdiploid range characteristic of 
apoptotic cells. 
FCM Analysis and Sorting.  Two-color FCM analysis was per- 
formed on fresh and cultured thymocytes and their subsets.  5-50 
x  104 cells were simultaneously stained with directly conjugated 
or biotinylated mAbs and the latter revealed by conjugated SA. 
Dead cells and debris were excluded by selective forward and 90  ~ 
scatter gating or PI (1/~g/ml) with essentially  the same results. 
2-10  x  103  cells  were  scored per  sample,  using  a  FACScan  | 
instrument.  Markers  were set to denote fluorescence  above that 
of the background obtained with no antibody or with isotype- 
matched controls (Fisher  Scientific).  LYSYS II software (Becton 
Dickinson & Co.) was used for data analysis. Sorting was performed 
on HSA + DN  cells stained  with c~CD44-  and c~CD25-specific 
mAb to isolate  CD44-CD25-  (CD25-TL) and CD44-CD25 + 
(CD25+TN) cells. Purity was >99%  upon reanalysis. 
RT-PCR ofbcl-2 mRNA.  This assay was performed exactly as 
previously described (18). The reactions underwent 45 cycles of PCR 
amplification (denaturation at 94~  for 1 min; primer annealing 
at 61~  for bcl-2 and at 55~  for ~-actin, for 2 min; primer exten- 
sion at 72~  for 3 min; and final extension at 72 ~ for 7 min). The 
forward and reverse primers for bcl-2 were as in reference 19; for 
~-actin, F(5'-GTG GGG CGC CCC AGG CAC CA-3') and R(5'- 
CTC CTT ATT GTC ACG CAC GAT TTC-3'). All were used 
at a final concentration of 0.2 #M. 
Results 
Differential Response of lmraature Thymocyte Subsets to Ca  2+ 
Elevation.  We  isolated  CD25-  CD8-4-TCR-  (CD25 + 
TN) thymocytes and their immediate progenitors,  CD25- 
CD81~176176  triple low (CD25-TL)  cells and stimu- 
lated them overnight with a calcium ionophore ionomycin. 
The viability of untreated (control) cells varied between 30 
and  90%  of the input  and  was  usually  slightly higher in 
CD25+TN  than in CD25-TL  cells (67.1  _+  16.4, n  =  8, 
and 51.5  _+  20.4, n  =  14, respectively), but the differences 
were never greater than 20%  within the same experiment. 
CD25+TN  thymocytes did  not  change  viability whether 
cultured  without  stimuli,  or in  the  presence  of PMA  or 
ionomycin (Table 1 and  data not  shown).  The number  of 
cells recovered from the CD25-TL cultures remained con- 
stant relative to control in the presence of PMA.  By con- 
trast,  ionomycin  dramatically  reduced  the  viability  of 
CD25-TL  subset  (Table 1). 
Phenotypic conversion of these two subsets into CD8hi4 hi 
(DP) ceils is shown in Table 1. CD25 +TN cells cannot un- 
dergo phenotypic change in vitro (10), and none of the stimuli 
used in this  study,  alone or in combination,  could induce 
them  to  do  so.  A  distinguishing  feature  of  CD25-TL 
thymocytes is their ability to convert to DP cells in vitro (10, 
11), and both PMA, ionomycin, and the combination of the 
two completely abrogated this conversion (Table 1, Fig.  1, 
1746  Calcium-mediated  Apoptosis in Early Thymocytes Table  1.  In  Vitro Survival and Conversion and In  Vivo Precursor Activity of Early Thyraocyte Subsets Stimulated with 
PMA and Ionomycin (Iono) 
No.  of 
Percent  donor-derived 
Conversion  Survival  Subset  donor-derived  cells/thymus 
In vitro  Subset  Stimulus  index  (Percent control)  In vivo  transferred  Stimulation  cells/thymus  (x 106) 
Exp.  1  CD25-TL  -  0.89  100  Exp.  1  CD25-TL  -  4.6;  3.4;  8.0 
PMA  0.10  104.2  Iono  0.4;  0.2 
Iono  0.10  6.8 
CD25*TN  -  0.01  100  Exp.  2*  CD25-TL  -  43.1  11.5 
PMA  0.01  101.6  Iono  0.2  0.2 
Iono  0.01  98.3  CD25*TN  -  69.8  24.1 
Iono  64.7  26.1 
CD25*TN  -  36.2;  38.0;  0.9  4.0;  9.5;  0.4 
Iono  10.6;  5.1;  13.9;  2.5;  1.3;  4.6; 
14.4;  26.7  3.6;  9.1 
Exp.  2  CD25-TL  -  2.35  100  Exp.  3 
Iono  0.16  16.3 
CD25+TN  -  0.01  100 
Iono  0.01  104.7  No transfer  -  0.3  0.1 
1.3;0.9;2.4 
0.1;0.1 
Thymocyte subsets were treated and analyzed as described in Materials and Methods and Fig. 1. Viability was determined by trypan blue exclusion, 
and ranged between 43 and 75% between experiments for untreated controls.  Control viability was taken as a reference point of 100%. For the 
in vivo studies, 2-7  ￿  10  s cells injected into thymuses of recipient mice (two to five/group, B6.PL in Exp.  1 and 2 and B6-Ly5.2 in Exp. 3). 
9-13 d later, individual host thymuses were analyzed for the presence of donor-derived progeny by FCM, and the results expressed as percent donor- 
derived cells, and as absolute numbers of donor-derived eeUs, calculated from the total number of thymocytes and the percent donor-derived cells. 
* Pooled thymocytes (four/group) were analyzed. In these experiments, CD25 +  TN population was 88-99%  CD25 hi and CD25 TL cells  contained 
between  1 and  10%  CD251~ cells. 
and data not  shown).  PMA was used as a positive control 
expected to inhibit conversion but not to induce apoptosis, 
since it was recently shown  that PMA inhibits conversion 
by inducing degradation of CD4 and CD8 mRNA  (20). The 
doses of PMA  and  ionomycin that  affect  CD25-TL  cells 
correspond to the ones required to elicit a proliferative re- 
sponse in mature T  cells (data not shown). Time course ex- 
periments demonstrated that each reagent needed at least 3- 
6  h  to inhibit conversion.  Together,  they acted synergisti- 
cally and caused a profound inhibition of conversion (21, and 
data not shown).  Finally, the addition of calcium chdators 
completely abrogated the effects of ionomycin, showing that 
the abrogation of conversion and cell death are due to Ca  2  + 
influx and not to nonspecific cytotoxicity of ionomycin (data 
not shown). 
To test the effect of caldum devation on the in vivo precursor 
capacity of the two early subsets, control and stimulated cells 
were introduced into the thymuses of Thy-1 or Ly-5 con- 
genic, irradiated recipients. Cultured cells from both subsets 
retain detectable, although diminished, in vivo precursor ac- 
tivity compared to freshly isolated cells (14, Table 1, and data 
not shown). To avoid bias due to variation in the ef~ciency 
of intrathymic injection, we performed individual analyses 
of injected thymuses. For both subsets,  the results of in- 
trathymic assays strictly paralleled the conversion and viability 
data. Namely, ionomycin completely abrogated the in vivo 
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Figure  1.  Ionomycin  inhibits  in  vitro  conversion of 
CD25-TL thymocytes into DP cells. Purified CD25-TL 
thymocytes were stained immediately after isolation (A), and 
cultured  without  stimulation  (B)  or  in  the  presence of 
ionomycin (C). Expression  of CD8 and CD4 was determined 
by FCM. Data from 5  x  10~ cells are shown as 80% loga- 
rithmic contour plots (threshold  =  3). (A) Markers are set 
to denote fluorescence above that of control, and it can be 
seen that TL ceils express low levels of CD8 and CD4.  (B 
and C) l~gion is drawn to denote bright DP cells.  The results 
are representative of more than 20 experiments. Table  2.  DNA Fragmentation in Immature Thymocyte Subsets and Their Nuclei in Response to Calcium Elevation 
Thymocyte  subsets  Nuclei 
Subset  Treatment  %  DNA fragmentation*  Nuclei from  Ion added  % DNA fragmentation* 
CD25-TL  -  48.5  CD25-TL 
Iono  71.3 
Dex  72.8 
CsA  48.8 
CsA  +  Iono  70.9 
CD25 +  TN  -  35.2  CD25 +  TN 
Iono  24.2 
Dex  81.6 
CsA  ND 
CsA +  Iono  ND 
Nil  19.8 
Mg  2+  8.2 
Ca  2  +  88.1 
Ca  2+  +  Mg  2+  ND 
Nil  35.3 
Mg  2+  8.4 
Ca  2+  85.4 
Ca  2+  +  Mg  2+  87.5 
Early thymocyte subsets were cultured with indicated stimuli in vitro, and their DNA content assayed as described in Materials and Methods. CD25 + 
TN thymocytes were 89.7% CD25 lai, and CD25-TL cells contained 11.9% CD25  io cells. CI for TL cells was: control, 17.1;  iono, 0.4; Dex, ND; 
CsA,  16.5;  iono  +  CsA,  0.1;  and for all TN <  0.1.  These cells were also used for the experiment shown in Fig.  2.  Results are representative 
of four experiments. Nuclei were isolated, treated, and tested as described in Materials and Methods. CI was 2.8 for TL and 0.03 for TN cells. 
At the beginning of culture neither subset contained any DP or SP cells. They were >99% HSA +, and TL and TN cells were 5.7 and 97.6% posi- 
tive for CD25,  respectively. 
* Determined as percent cells with clearly  subdiploid DNA content, as described (20). 
precursor activity of the CD25- TL cells. By contrast, this 
agent  caused  no  changes  in  the  precursor  activity  of 
CD25+TN  cells (Table  1). 
Elevation of lntracellular Ca  2+ Induces Apoptosis in CD25- 
TL but not in CD25 +  TN Cells.  Next, we investigated the 
mechanism of cell death in thymocyte subsets after stimula- 
tion using a quantitative flow cytometric assay of DNA ploidy 
(16). Both cell subsets exhibited high background DNA flag- 
mentation (30-55% in six experiments), consistent with spon- 
taneous death of these cells outside the thymus (Table 2). 
PMA, used as a control reagent, did not affect fragmentation 
of either subset (data not shown). CD25-TN cells markedly 
increased DNA fragmentation in the presence of ionomycin. 
By contrast, ionomycin could not induce fragmentation in 
CD25 +  TN cells. Dexamethasone treatment induced a near- 
complete DNA fragmentation in both subsets, demonstrating 
that CD25+TN  cells are resistant to CMCD but  are not 
generally resistant to apoptosis.  Together, these results indi- 
cate that a specific developmental difference in sensitivity to 
CMCD  exists  between  CD25+TN  and  CD25-TL  cells. 
Importantly, CsA could not reverse the Ca  2  +-induced apop- 
toffs of TL cells suggesting that calcineurin (22, 23) is not 
involved in  the transduction  of Ca2+-mediated  apoptotic 
signals. 
Several control experiments were performed to ascertain 
that FCM measurements detect apoptosis, rather than nonspe- 
cific cell death. Microscopic appearance of Ca  2  +-stimulated 
CD25-TL  and steroid-treated CD25+TN  and CD25-TL 
cells,  but not of Ca2+-stimulated CD25+TN  thymocytes, 
was consistent with apoptosis.  DNA laddering was always 
detected in apoptotic samples and never in freshly isolated 
cells, but was quantitatively noninformative owing to the 
high background in cultured ceils. Finally,  the process was 
inhibited by cyclohexamide in all samples and by EGTA in 
calcium-stimulated ones (data not shown). 
A Ca2+-dependent endogenous endonuclease was impli- 
cated as the effector of fragmentation (5, 7). To test whether 
the effector(s) of the apoptotic pathw~; exists and is func- 
tional in CD25+TN cells, we isolated nuclei from CD25- 
TL and CD25+TN thymocytes, and incubated them in the 
presence or absence of Ca  2  + or Mg  2  +. Control magnesium 
ions did not induce fragmentation above that of the back~ 
ground (Table 2). By contrast, calcium ions induced a pro- 
found fragmentation of DNA in nuclei isolated from both 
subsets  (Table  2).  The  resistance  of CD25+TN  cells  to 
CMCD could in theory be due to the possibility that these 
cells  poorly elevate  Ca  2+  in  response  to  ionomycin. The 
analysis of Ca  2+ fluxes in Fluo-3-1oaded thyrnocyte subsets 
revealed, however, that both subsets are able to mobilize equally 
high Ca  2+ levels (data not shown). There is, therefore, no 
difference between the two subsets at the most proximal and 
most distal steps  of the CMCD pathway. 
Expression of bd-2 in Early Thymocyte Subsets Directly Corre- 
lates to Their Resistance to CMCD  Protooncogene bcl-2 was 
recently shown to play a role in T  cell apoptosis (24, 25). 
We therefore examined the presence ofbcl-2 mKNA in thymo- 
cyte subsets by sensitive KT-PCR analysis. The message was 
absent in total thymocytes (Fig. 2, lane 6), strong in spleno- 
cytes (Fig. 2, lane 10) and detectable, but at low level, in ma- 
ture HSA-  thymocytes. Among early thymocyte subsets, 
1748  Calcium-mediated Apoptosis in Early Thymocytes Figure 2.  RT-PCR detection of bcl.2 mRNA in thymocyte  subsets. 
~-actin (lanes  I-5) and bcl-2  (lanes  6-10) mRNA was detected  by RT-PCR 
in total cellular  RNA isolated from: unfractionated  thymocytes  (lanes 1 
and 6); CD25+TN thymocytes  (lanes  2 and 7); CD25-TL thymocytes 
(lanes 3 and 8); HSA- thymocytes  (lanes  4 and 9); and total splenocytes 
(lanes 5 and 10). Molecular  weight markers  (1-kb DNA ladder; GIBCO 
BRL) are shown on both sides in unmarked  lanes, and the position of 
1-kb and 516-bp markers  denoted  to the left. Primers  were designed  to 
amplify  a 860-bp fragment  ofkb2 and a 548-bp fragment  of~-actin.  Similar 
results were  obtained  in four  other experiments.  Purities  and CI are shown 
in Table 2. 
CD25+TN cells expressed high levels of bcl-2 mRNA (Fig. 
2,  lane 7).  By contrast, we could not detect bcl-2  mRNA 
in CD25-TL  thymocytes (Fig.  2, lane 8).  RNA quantities 
used in this experiment were comparable, based on the RT- 
PCR amplification offl-actin (Fig. 2, lanes 1-5). These results 
suggest that the pattern of expression of bcl-2 may account 
for the drastic difference in  sensitivity of early thymocyte 
subsets  to  Ca2+-induced  signals.  Moreover,  the results  of 
testing of other thymocyte subsets (Fig.  2) suggest that the 
expression of bcl-2 may be restricted to the earliest, TCR-, 
and the most mature, HSA-  stages of intrathymic develop- 
ment.  This is because no bcl.2  message can be detected in 
total thymocytes, more than 80%  of which are DP. 
Discussion 
It is generally believed that calcium is a critical second mes- 
senger in  the induction of apoptosis  via  the TCR  (2-4). 
Ca  2+ signaling is therefore considered to form the biochem- 
ical basis  of negative intrathymic selection, but the down- 
stream signal transduction after the transmembrane influx 
of Ca  2+ is poorly understood. Another type of poorly un- 
derstood death by apoptosis that could be mediated by Ca  2+ 
is even more frequent in the thymus and is due to a lack of 
positive selection (death by "neglect"). Here we show that 
CD25+TN  thymocytes  display  a  selective  resistance  to 
Ca  2  +-mediated apoptosis.  As soon as the TCR and the ac- 
cessory molecules are expressed on developing T  cells, this 
resistance is lost,  and the cells become exquisitely sensitive 
to the elevation ofintracellular calcium,  just as their immediate 
progeny, TCR  l~  DP thymocytes. CD25+TN cells are not 
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generally resistant to apoptosis,  as steroids readily induce their 
death. Since steroids operate via a unique nuclear receptor(s) 
(8), steroid-induced apoptosis should be quite distinct from 
the induction of apoptosis via the TCR, during which the 
Ca2+-generated  signal  presumably  travels  through  the 
cytoplasm. In that respect, it is important  to determine if 
and at what point do CMCD and steroid-induced apoptotic 
pathways intersect and/or converge. 
We did not  detect differences between CD25+TN  and 
CD25-TL cells in the most proximal (Ca  2+  mobilization) 
and the most distal (endonuclease activation) points of the 
apoptotic  pathway.  An  obligatory  player  in  the  Ca  2+- 
mediated T cell activation, caldneurin, appears not to be re- 
quired for the transduction of a  Ca  2  +-mediated apoptotic 
signal in CD25-TL  cells, judging by the inability of CsA 
to inhibit apoptosis.  CsA was shown to abrogate apoptosis 
and negative selection in some (4, 26, 27) but not other (28, 
29) experimental systems. Our results are consistent with the 
proposal of Ucker et al. (29) that CsA cannot inhibit apop- 
toffs induced by a single signal.  Ca  2+-mediated, calcineurin- 
independent induction of apoptosis may suggest the existence 
of independent and parallel pathways of Ca  2+  action:  one 
would lead to T cell activation, the other to thymocyte  death. 
What biochemical change(s) dictates the transition from 
CMCD resistance to sensitivity? An abrupt cessation of bcl-2 
mRNA  expression in  CD25-TL  cells  correlates with  the 
onset of sensitivity to apoptosis.  The role of bcl-2 in blocking 
apoptosis is well established (19, 24, 25).  Our results docu- 
ment its expression in early (CD25 +TN) and late (HSA-), 
but not intermediate (CD25-TL and DP) thymocytes, bcl-2 
could therefore play a major role in the developmental regu- 
lation of CMCD. Since a deregulated overexpression of bcl-2 
does not appear to grossly perturb clonal deletion (24, 25), 
and in light of our results indicating a lack of or very low 
expression of this molecule in selectable  (DP)  thymocytes, 
bcl.2 probably does not play a significant physiological role 
in negative selection. Furthermore, in our studies, bcl-2 does 
not  protect  CD25+TN  cells  from  steroid-induced death. 
This is in contrast with the observation that in transgenic 
animals bcl-2 prevents steroid-induced death of unseparated 
thymocytes (24, 25). The most likely explanation of this dis- 
crepancy is that levels of bcl-2 expression were supraphysio- 
logical in thymocytes of transgenic animals, whereas our study 
did not manipulate physiological levels of bcl.2  expression. 
We propose that the physiological role of bcl-2 may be to 
make early thymocytes and mature T cells relatively resistant 
to apoptosis,  and that its absence renders intermediate thymo- 
cytes susceptible to death by neglect, unless they are rescued 
by positive  selection.  Whether  death  by neglect involves 
Ca  2+ as the key messenger and what cell surface structures 
induce this process is under study. The role ofbcl-2 and other 
molecules such as Fas (30) and c-myc (31) in T cell develop- 
ment and whether they act using the same or different sig- 
naling pathways are questions of paramount importance to 
our understanding of thymocyte apoptosis. 
Resistance to TCR-mediated deletion was demonstrated 
previously in a subset of fetal DP thymocytes (32, 33), using 
differential susceptibility of these cells  to anti-CD3  versus anti-TCK-odB mAb treatment. But these results have not 
been reproduced in the adult thymus to date. We now show 
that early adult thymocyte populations are protected from 
Ca  2  +-mediated cell death until they begin to express CD8, 
CD4, and TCK. The expression  of even very low amounts 
of these molecules correlates with an exquisite sensitivity to 
Ca  2+  elevation.  Calcium-driven cell  death  is  therefore  a 
"privilege" bestowed upon thymocytes that reach the selec- 
tion stage,  perhaps by downregulation of bcl-2 expression. 
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Note added in proof: While this manuscript was in press, two groups have assayed the expression of the 
Bd-2 protein in human (Gratiot-Deans et al.,J. Immunol.  151:83, 1993) and human and mouse (Veis et 
al.,J. Immunol. 151:2546, 1993) thymocytes. Although some  differences  exist between these findings and 
the ones reported here (most likely owing to different assays used to detect Bcl-2) the common finding 
of all three studies is that Bcl-2 is expressed at high levels early and late in thymocyte development and 
at low levels in DP thymocytes. 
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